Product Pathways - Cell Cycle / Checkpoint
CDK Antibody Sampler Kit #9868
|9868S||1 Kit (6 x 40 µl)||---||In Stock||---|
Already purchased this product? Write a Review.
|Kit Includes||Quantity||Applications||Reactivity||MW (kDa)||Isotype|
|cdc2 (POH1) Mouse mAb #9116||40 µl||W, IP, IF-IC||H, Mk||34||Mouse IgG2a|
|CDK2 (78B2) Rabbit mAb #2546||40 µl||W, IP, F||H, M, R, Mk||33||Rabbit IgG|
|CDK4 (D9G3E) Rabbit mAb #12790||40 µl||W, IHC-P, IF-IC||H, Mk||30||Rabbit IgG|
|CDK6 (D4S8S) Rabbit mAb #13331||40 µl||W, IP||H, Mk||36||Rabbit IgG|
|CDK7 (MO1) Mouse mAb #2916||40 µl||W, IP, IHC-P||H, R||40||Mouse IgG2b|
|CDK9 (C12F7) Rabbit mAb #2316||40 µl||W, IP, IHC-P, IHC-F, IF-IC, F||H, M, R, Hm, Mk, B, Dg||42, 55||Rabbit IgG|
|Anti-rabbit IgG, HRP-linked Antibody #7074||100 µl||Goat|
|Anti-mouse IgG, HRP-linked Antibody #7076||100 µl||Horse|
Applications Key: W=Western Blotting, IP=Immunoprecipitation, IF-IC=Immunofluorescence (Immunocytochemistry), F=Flow Cytometry, IHC-P=Immunohistochemistry (Paraffin), IHC-F=Immunohistochemistry (Frozen)
Reactivity Key: H=Human, Mk=Monkey, M=Mouse, R=Rat, Hm=Hamster, B=Bovine, Dg=Dog
Western blot analysis of extracts from various cell lines using CDK4 (D9G3E) Rabbit mAb #12790.
Western blot analysis of extracts from HeLa, Jurkat, and COS-7 cells using CDK6 (D4S8S) Rabbit mAb #13331.
Western blot analysis of extracts from HeLa, NIH/3T3 and C6 cells using CDK9 (C12F7) Rabbit mAb #2316.
Western blot analysis of extracts from various cell types using CDK2 (78B2) Rabbit mAb #2546.
Western blot analysis of extracts from SK-N-MC and C6 cells using CDK7 (MO1) Mouse mAb #2916.
Western blot analysis of extracts from HeLa cells synchronized at various stages of the cell cycle, using cdc2 (POH1) Mouse mAb #9116.
The CDK Antbody Sampler Kit provides and economical means of evaluating Cdk proteins. The kit contains enough primary and secondary antibodies to perform four western blot experiments.
Specificity / Sensitivity
Each antibody in the CDK Antibody Sampler Kit detects endogenous levels of its respective target protein and does not cross-react with other family members.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a recombinant human cdc2 fusion protein, synthetic peptides corresponding to residues of human CDK2 and recombinant human CDK7, and residues near the carboxy terminus of human CDK4, human CDK6, and human CDK9 proteins.
Cyclin-dependent kinases (CDKs) are the core effectors of cell cycle progression. CDK activity is regulated through association with their cyclin partners and cyclin-dependent kinase inhibitors (CKIs) as well as by activating and inhibitory phosphorylation events. Inhibition is mediated by Wee1 and Myt1 kinases that target residues at the amino terminus of CDK1 (1,2). Dephosphorylation of these residues by cdc25 phosphatase leads to activation of CDK kinase activity (3). The CDK7/cyclinH complex is the ubiquitous mammalian CDK-activating kinase (CAK) that phosphorylates a conserved threonine residue in the T-loop domain of CDKs. The carboxy-terminal domain of RNA polymerase II is also a target of CAK as well as CDK9/cyclinT (4,5). CDK4/6 associate with cyclinD and phosphorylate retinoblastoma protein and initiate progression through the restriction point in G1 (6). CDK2 associates with cyclinE in early S phase and cyclinA later in G2. CDK1/cyclinB regulates the initiation of mitotic events (7).
- Fattaey, A. and Booher, R.N. (1997) Prog Cell Cycle Res 3, 233-40.
- Booher, R.N. et al. (1997) J Biol Chem 272, 22300-6.
- Jessus, C. and Ozon, R. (1995) Prog Cell Cycle Res 1, 215-28.
- Kaldis, P. (1999) Cell Mol Life Sci 55, 284-96.
- De Falco, G. and Giordano, A. Cancer Biol Ther 1, 342-7.
- Sherr, C.J. (1995) Trends Biochem Sci 20, 187-90.
- Morgan, D.O. (1997) Annu Rev Cell Dev Biol 13, 261-91.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
* Product-specific protocol.
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
Select rabbit monoclonal antibodies are developed, validated, and produced at CST using in part technology under license (granting certain rights including those under U.S. Patents No. 5,675,063 and in some instances 7,429,487) from Epitomics, Inc.